Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system

The mammalian target of rapamycin (mTOR) inhibitors, a set of promising potential anti-cancer agents, has shown response variability among individuals. This study aimed to identify novel biomarkers and mechanisms that might influence the response to Rapamycin and Everolimus. Genome-wide association...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jing, Fridley, Brooke L., Feng, Qiping, Abo, Ryan P., Brisbin, Abra, Batzler, Anthony, Jenkins, Gregory, Long, Pamela A., Wang, Liewei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/
https://www.ncbi.nlm.nih.gov/pubmed/24009623
http://dx.doi.org/10.3389/fgene.2013.00166

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3757297/
https://www.ncbi.nlm.nih.gov/pubmed/24009623
http://dx.doi.org/10.3389/fgene.2013.00166

Ejemplares similares